{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":14,"n_cols":5,"rows_kept":14,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910880294003321"]
[null,null,"Autore",null,"Berger Stephen"]
[null,null,"Titolo",null,"Tularemia"]
[null,null,"Pubbl/distr/stampa",null,"Los Angeles : , : Gideon Informatics, Incorporated, , 2024"]
[{"$nulls":4},"©2024"]
[null,null,"ISBN",null,"1-4988-4656-4"]
[null,null,"Edizione",null,"[2024th ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (98 pages)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Tularemia -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Bioterrorism -- References -- Afghanistan -- References -- Albania -- Algeria -- References -- American Samoa -- Andorra -- Antigua and Barbuda -- References -- Armenia -- References -- Australia -- References -- Austria -- References -- Azerbaijan -- References -- The Bahamas -- References -- Belarus -- References -- Belgium -- References -- Bosnia and Herzegovina -- References -- Bulgaria -- References -- Canada -- References -- China -- References -- Croatia -- References -- Cyprus -- The Czech Republic -- References -- Denmark -- References -- Egypt -- References -- Estonia -- References -- Finland -- References -- France -- References -- Georgia -- References -- Germany -- References -- Greece -- References -- Guam -- Hungary -- References -- Iceland -- Iran -- References -- Ireland -- Israel -- Italy -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kosovo -- References -- Latvia -- Liechtenstein -- References -- Lithuania -- References -- Luxembourg -- References -- Malta -- Mexico -- References -- Moldova -- References -- Mongolia -- References -- Montenegro -- References -- The Netherlands -- References -- North Macedonia -- The Northern Marianas -- Norway -- References -- Pakistan -- References -- Poland -- References -- Portugal -- "]
[{"$nulls":4},"References -- Puerto Rico -- South Korea -- References -- Romania -- References -- The Russian Federation -- References -- San Marino -- Scotland."]
[{"$nulls":4},"References -- Serbia -- References -- Slovakia -- References -- Slovenia -- References -- South Africa -- References -- Spain -- References -- Sweden -- References -- Switzerland -- References -- Taiwan -- References -- Thailand -- References -- Turkey -- References -- Turkmenistan -- Ukraine -- References -- The United Kingdom -- References -- The United States -- References -- Uzbekistan -- The U.S. Virgin Islands -- Vaccines &amp -- Immunoglobulins -- Tularemia vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Tularemia vaccine (1 listed) -- Contraindications for Tularemia vaccine (3 listed) -- Trade names of Tularemia vaccine (0 listed) -- About GIDEON."]